Prenetics (PRE) Q2 FY26 earnings call

Prenetics delivered a strong Q2 FY26, achieving record revenue and reaching adjusted free cash flow positive status in July, ahead of expectations. The company raised its full-year 2026 and initiated 2027 revenue guidance, driven by robust customer acquisition at lower costs and the strategic General Catalyst funding. Management emphasized its AI-native operational efficiency and commitment to science-backed product development, with new hydration and gummy products planned for launch.